TCI Co. Ltd. Introduces a New GLP-1 Formula
TCI Co. Ltd. (8436.TWO), a company with more than 40 years in the health and cosmetic industries, has unveiled an innovative GLP-1 formula. Built from plant extracts, probiotics, and prebiotics, the product focuses on natural weight management—supporting the body’s own signals rather than forcing short-term change.
Why Weight Management Needs Better Options
Obesity continues to rise worldwide. According to WHO, more than a billion people are now classified as obese, and the financial impact is on track to be severe. By 2035, global economic costs linked to obesity may exceed $4 trillion each year. At the same time, demand for better tools is growing: the weight loss and obesity drug market is projected to reach $150 billion by the early 2030s. The need is clear; effective, sustainable solutions matter.
How TCI's GLP-1 Formula Works
TCI’s approach centers on its proprietary Bio-Resource Data Mining technology—an AI-driven system designed to sift through natural sources and pinpoint promising compounds. Those discoveries form the backbone of the new GLP-1 formula. In-vitro tests, along with human studies, indicate the formula can stimulate natural GLP-1 secretion, a hormone response tied to fat metabolism, steadier blood glucose, and the browning of white fat.
In internal trials, participants saw meaningful support for their weight management goals. By nudging the body to boost its own GLP-1 production—especially from intestinal L-cells—the formula aims to curb appetite in a sustainable way and promote fat loss without leaning on extreme measures.
Putting It to Work with TCI’s Own Team
To better understand day-to-day impact, TCI invited employees to try the GLP-1 formula. Over two months, participants lost an average of 4.9 kg. The experience reinforced interest inside the company in practical, healthier routines that build over time. To fit different preferences, the GLP-1 product comes in liquids, powder sachets, and tablets. It’s also positioned for international rollout through partnerships with global enterprises.
What GLP-1 Is—and Why It Matters
GLP-1 (Glucagon-Like Peptide-1) is a hormone released by intestinal L-cells, mainly in response to eating. It helps regulate insulin release, reduce appetite, and slow gastric emptying. Put simply, GLP-1 supports the body’s own checks and balances that are central to weight management.
Evidence Behind TCI’s GLP-1 Formula
Findings presented by TCI point to several clinical benefits tied to the formula:
Increased GLP-1 Secretion
In controlled settings, participants who consumed the GLP-1 formula showed a 10.3% rise in GLP-1 levels within one hour. That increase is associated with steadier appetite control shortly after meals.
Blood Glucose Stabilization
When the formula was taken with breakfast, measurements of post-meal blood sugar spikes dropped by 97%. The result suggests improved stability after eating—an effect that can support everyday energy management.
Weight Management Efficiency
Over four weeks, participants experienced improvements in total cholesterol, with beneficial shifts in HDL and LDL measures. These changes support cardiovascular health while contributing to weight management progress.
Looking Ahead with TCI
With this GLP-1 formula, TCI continues to develop natural, science-informed approaches that align with growing market needs. The focus is straightforward: help the body lean on its own GLP-1 system to manage appetite, metabolism, and glucose, then keep building on what works. It’s a measured step—one meant to last.
Frequently Asked Questions
What exactly is TCI’s new GLP-1 formula?
It’s a product developed by TCI that combines plant extracts, probiotics, and prebiotics to support natural weight management by working with the body’s own GLP-1 response.
How does the formula help with weight control?
By promoting natural GLP-1 secretion, the formula helps manage appetite, steadies post-meal blood sugar, and supports fat metabolism—key levers for weight management.
What results did TCI employees see?
In an internal two-month tryout, participating employees lost an average of 4.9 kg, suggesting the formula can be a helpful part of a weight management plan.
In what formats can I get the GLP-1 product?
It’s available as liquids, powder sachets, and tablets, offering options that fit different daily routines.
How large is the market for weight loss solutions?
Projections indicate the weight loss and obesity drug market could reach $150 billion by the early 2030s, reflecting strong and growing demand for effective support.
